Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806-8012
    BD:
    East and South China:Ms. Gu 15378638068
    North China, East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Project Management Department:0512-69998806-8022
    Tumor business:0512-69998806-8058
    Non tumor business:0512-69998806-8026
    Pathogenic microorganism business:0512-69998806-8037
    Integrated Service Platform:0512-69998806-8022
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key models for drug development in hyperlipidemia

Hyperlipidemia, also known as hyperlipidemia or dyslipidemia, usually refers to elevated plasma triglycerides and/or total cholesterol, elevated LDL cholesterol, and decreased HDL cholesterol. Hyperlipidemia carries the risk of complicating diseases such as coronary heart disease and cerebrovascular disease.
   We have established a stable model of hyperlipidemia, which is suitable for preclinical research and new drug evaluation of drugs for hyperlipidemia.
   If you have project needs and experience more of our professional services, please contact us.

Our services

Model classification

Model Name

Animal species

Hyperlipidemia

hyperlipidemia induced by high-fat feed alone

Rat,Rabbit

Hyperlipidemia model induced by high fat and high cholesterol feeds

Mice,golden gophers,rabbit,dogs, non-human primates

Case sharing

Next:Liver fibrosis/cirrhosis